Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3 F1 deletions

Human Mutation

Volumn 33, Issue 2, 2012, Pages 372-383

  Zickler, Antje M ^a   Hampp, Stephanie ^a   Messiaen, Ludwine ^b   Bengesser, Kathrin ^a   Mussotter, Tanja ^a   Roehl, Angelika C ^a   Wimmer, Katharina ^c   Mautner, Victor Felix ^d   Kluwe, Lan ^d   Upadhyaya, Meena ^e   Pasmant, Eric ^f   Chuzhanova, Nadia ^g   Kestler, Hans A ^a   Högel, Josef ^a   Legius, Eric ^h   Claes, Kathleen ⁱ   Cooper, David N ^e   Kehrer Sawatzki, Hildegard ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f INSERM   (France)

^g NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Gene conversion; Neurofibromatosis type 1; Nf1; Nonallelic homologous recombination hotspot

Indexed keywords

NEUROFIBROMIN;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE DOSAGE; GENE LOCUS; GENOTYPE; HOMOLOGOUS RECOMBINATION; MOSAICISM; NONALLELIC HOMOLOGOUS RECOMBINATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PSEUDOGENE; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOME BREAKPOINTS; GENE CONVERSION; GENE DELETION; GENE ORDER; GENES, NEUROFIBROMATOSIS 1; HOMOLOGOUS RECOMBINATION; HUMANS; MOSAICISM; NEUROFIBROMATOSIS 1; NUCLEOTIDE MOTIFS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84857061060     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21644     Document Type: Article

References (68)

1. Abeysinghe SS, Chuzhanova N, KrawczakM, Ball EV, Cooper DN. 2003. Translocation and gross deletion breakpoints in humaninherited disease and cancer I:Nucleotide composition and recombination-associated motifs. Hum Mutat 22:229-244.
2. Ball EV, Stenson PD, Abeysinghe SS, Krawczak M, Cooper DN, Chuzhanova NA. 2005. Microdeletions and microinsertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum Mutat 26:205-213.
3. Barrett JC, Fry B, Maller J, DalyMJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
4. Baudat F, Buard J, Grey C, Fledel-Alon A, Ober C, Przeworski M, Coop G, de Massy B. 2010. PRDM9 is a major determinant of meiotic recombination hotspots in humans and mice. Science 327:836-840.
5. Baudat F, de Massy B. 2007. Regulating double-stranded DNA break repair towards crossover or non-crossover duringmammalian meiosis. ChromosomeRes 15:565-577.
6. Bayés M, Magano LF, Rivera N, Flores R, Pérez Jurado LA. 2003. Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet 73:131-151.
7. Bengesser K, Cooper DN, Steinmann K, Kluwe L, Chuzhanova NA, Wimmer K, Tatagiba M, Tinschert S, Mautner VF, Kehrer-Sawatzki H. 2010. Novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2. Hum Mutat 31:742-751.
8. Berg IL, Neumann R, Lam KW, Sarbajna S, Odenthal-Hesse L, May CA, Jeffreys AJ. 2010. PRDM9 variation strongly influences recombination hot-spot activity and meiotic instability in humans. Nat Genet 42:859-863.
9. Bosch E, HurlesME, Navarro A, Jobling MA. 2004. Dynamics of a human interparalog gene conversion hotspot. Genome Res 14:835-844.
10. Bosch E, Jobling MA. 2003. Duplications of the AZFa region of the human Y chromosome are mediated by homologous recombination between HERVs and are compatible with male fertility. Hum Mol Genet 12:341-347.
11. Chowdhury R, Bois PR, Feingold E, Sherman SL, Cheung VG. 2009. Genetic analysis of variation in human meiotic recombination. PLoS Genet 5:e1000648.
12. Chuzhanova N, Chen JM, Bacolla A, Patrinos GP, Férec C, Wells RD, Cooper DN. 2009. Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat 30:1189-1198.
13. Conrad DF, Bird C, Blackburne B, Lindsay S, Mamanova L, Lee C, Turner DJ, Hurles ME. 2010. Mutation spectrum revealed by breakpoint sequencing of human germline CNVs. Nat Genet 42:385-391.
14. Coop G, Wen X, Ober C, Pritchard JK, Przeworski M. 2008.High-resolutionmapping of crossovers reveals extensive variation in fine-scale recombination patterns among humans. Science 319:1395-1398.
15. Crawford DC, Bhangale T, Li N, Hellenthal G, Rieder MJ, Nickerson DA, Stephens M. 2004. Evidence for substantial fine-scale variation in recombination rates across the human genome. Nat Genet 36:700-706.
16. Cullen M, Perfetto SP, Klitz W, Nelson G, Carrington M. 2002.High-resolution patterns of meiotic recombination across the human major histocompatibility complex. Am J Hum Genet 71:759-776.
17. De Raedt T, Brems H, López-Correa C, Vermeesch JR, Marynen P, Legius E. 2004. Genomic organization and evolution of the NF1 microdeletion region. Genomics 84:346-360.
18. De Raedt T, StephensM, Heyns I, Brems H, Thijs D, Messiaen L, Stephens K, Lazaro C, Wimmer K, Kehrer-Sawatzki H, Vidaud D, Kluwe L, Marynen P, Legius E. 2006. Conservation of hotspots for recombination in low-copy repeats associated with the NF1 microdeletion. Nat Genet 38:1419-1423.
19. Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K. 2000. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 9:35-46.
20. Forbes SH, Dorschner MO, Le R, Stephens K. 2004. Genomic context of paralogous recombination hotspots mediating recurrent NF1 region microdeletion. Genes Chrom Cancer 41:12-25.
21. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, Wheeler DA, Willis TD, Yu F, Yang H, Zeng C, Gao Y, Hu H, HuW, Li C, Lin W, Liu S, Pan H, Tang X, Wang J, Wang W, Yu J, Zhang B, Zhang Q, Zhao H, Zhao H, Zhou J, Gabriel SB, Barry R, Blumenstiel B, Camargo A, Defelice M, Faggart M, Goyette M, Gupta S, Moore J, Nguyen H, OnofrioRC, ParkinM, Roy J, Stahl E, Winchester E, ZiaugraL, Altshuler D, Shen Y, Yao Z, Huang W, Chu X, He Y, Jin L, Liu Y, Shen Y, Sun W, Wang H, Wang Y, Wang Y, Xiong X, Xu L, Waye MM, Tsui SK, Xue H, Wong JT, Galver LM, Fan JB, GundersonK, Murray SS, Oliphant AR, CheeMS, MontpetitA, Chagnon F, Ferretti V, Leboeuf M, Olivier JF, Phillips MS, Roumy S, Sallée C, Verner A, Hudson TJ, Kwok PY, CaiD, Koboldt DC, Miller RD, Pawlikowska L, Taillon-Miller P, Xiao M, Tsui LC, Mak W, Song YQ, Tam PK, Nakamura Y, Kawaguchi T, Kitamoto T, Morizono T, Nagashima A, Ohnishi Y, Sekine A, Tanaka T, Tsunoda T, Deloukas P, Bird CP, Delgado M, Dermitzakis ET, Gwilliam R, Hunt S, Morrison J, PowellD, Stranger BE, Whittaker P, Bentley DR, Daly MJ, de Bakker PI, Barrett J, Chretien YR, Maller J, McCarroll S, PattersonN, Pe'er I, Price A, Purcell S, RichterDJ, Sabeti P, Saxena R, Schaffner SF, Sham PC, Varilly P, Altshuler D, Stein LD, Krishnan L, Smith AV, Tello-Ruiz MK, Thorisson GA, Chakravarti A, Chen PE, Cutler DJ, Kashuk CS, Lin S, Abecasis GR, Guan W, Li Y, Munro HM, Qin ZS, Thomas DJ, McVean G, Auton A, Bottolo L, Cardin N, Eyheramendy S, Freeman C, Marchini J, Myers S, Spencer C, Stephens M, Donnelly P, Cardon LR, Clarke G, Evans DM, Morris AP, Weir BS, Tsunoda T, Mullikin JC, Sherry ST, Feolo M, Skol A, Zhang H, Zeng C, Zhao H, Matsuda I, Fukushima Y, Macer DR, Suda E, Rotimi CN, Adebamowo CA, Ajayi I, Aniagwu T, Marshall PA, Nkwodimmah C, Royal CD, Leppert MF, Dixon M, Peiffer A, Qiu R, Kent A, Kato K, Niikawa N, Adewole IF, Knoppers BM, FosterMW, Clayton EW, Watkin J, Gibbs RA, Belmont JW, Muzny D, Nazareth L, Sodergren E, Weinstock GM, Wheeler DA, Yakub I, Gabriel SB, Onofrio RC, Richter DJ, Ziaugra L, Birren BW, DalyMJ, Altshuler D, Wilson RK, Fulton LL, Rogers J, Burton J, Carter NP, Clee CM, Griffiths M, JonesMC, McLay K, Plumb RW, Ross MT, Sims SK, Willey DL, Chen Z, Han H, Kang L, Godbout M, Wallenburg JC, L'Archevêque P, Bellemare G, Saeki K, Wang H, An D, Fu H, Li Q, Wang Z, Wang R, Holden AL, Brooks LD, McEwen JE, Guyer MS, Wang VO, Peterson JL, Shi M, Spiegel J, Sung LM, Zacharia LF, Collins FS, Kennedy K, Jamieson R, Stewart J. International HapMap Consortium. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851-861.
22. FredmanD, White SJ, Potter S, Eichler EE, DenDunnen JT, Brookes AJ. 2004. Complex SNP-related sequence variation in segmental genome duplications. Nat Genet 36:861-866.
23. Hallast P, Nagirnaja L, Margus T, Laan M. 2005. Segmental duplications and gene conversion: human luteinizing hormone/chorionic gonadotropin beta gene cluster. Genome Res 15:1535-1546.
24. Hurles ME. 2001. Gene conversion homogenizes the CMT1A paralogous repeats. BMC Genomics 2:11.
25. Jeffreys AJ, Kauppi L, Neumann R. 2001. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat Genet 29:217-222.
26. Jeffreys AJ, May CA. 2004. Intense and highly localized gene conversion activity in human meiotic crossover hot spots. Nat Genet 36:151-156.
27. Jeffreys AJ, Neumann R. 2002. Reciprocal crossover asymmetry and meiotic drive in a human recombination hot spot. Nat Genet 31:267-271.
28. Jeffreys AJ, Neumann R. 2005. Factors influencing recombination frequency and distribution in a human meiotic crossover hotspot. Hum Mol Genet 14:2277-2287.
29. Jeffreys AJ, Neumann R, Panayi M, Myers S, Donnelly P. 2005. Human recombination hot spots hidden in regions of strong marker association. Nat Genet 37:601-606.
30. Jenne DE, Tinschert S, Dorschner MO, Hameister H, Stephens K, Kehrer-Sawatzki H. 2003. Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse. Genes Chrom Cancer 37:111-120.
31. Jenne DE, Tinschert S, ReimannH, Lasinger W, ThielG, Hameister H, Kehrer-Sawatzki H. 2001.Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. Am J Hum Genet 69:516-527.
32. Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer K, Krammer U, Peyrl A, Jenne DE, Hansmann I, Mautner VF. 2004. High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet 75:410-423.
33. Kidd JM, Graves T, Newman TL, Fulton R, Hayden HS, Malig M, Kallicki J, Kaul R, Wilson RK, Eichler EE. 2010. A human genome structural variation sequencing resource reveals insights into mutational mechanisms. Cell 143:837-847.
34. Kluwe L, Siebert R, Gesk S, Friedrich RE, Tinschert S, Kehrer-Sawatzki H, Mautner VF. 2004. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat 23:111-116.
35. Kong A, Thorleifsson G, Stefansson H, Masson G, Helgason A, Gudbjartsson DF, Jonsdottir GM, Gudjonsson SA, Sverrisson S, Thorlacius T, Jonasdottir A, Hardarson GA, Palsson ST, Frigge ML, Gulcher JR, Thorsteinsdottir U, Stefansson K. 2008. Sequence variants in the RNF212 gene associate with genome-wide recombination rate. Science 319:1398-1401.
36. Lammert M, Friedman JM, Kluwe L, Mautner VF. 2005. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 141:71-74.
37. Li N, Stephens M. 2003. Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data. Genetics 165:2213-2233.
38. Lindsay SJ, Khajavi M, Lupski JR, Hurles ME. 2006. A chromosomal rearrangement hotspot can be identified frompopulation genetic variation and is coincident with a hotspot for allelic recombination. Am J Hum Genet 79:890-902.
39. Locke DP, Hillier LW, Warren WC, Worley KC, Nazareth LV, Muzny DM, Yang SP, Wang Z, Chinwalla AT, Minx P, Mitreva M, Cook L, Delehaunty KD, Fronick C, Schmidt H, Fulton LA, Fulton RS, Nelson JO, Magrini V, Pohl C, Graves TA, Markovic C, Cree A, Dinh HH, Hume J, Kovar CL, Fowler GR, Lunter G, Meader S, Heger A, Ponting CP, Marques-Bonet T, Alkan C, Chen L, Cheng Z, Kidd JM, Eichler EE, White S, Searle S, Vilella AJ, Chen Y, Flicek P, Ma J, Raney B, Suh B, Burhans R, Herrero J, Haussler D, Faria R, Fernando O, Darré F, Farré D, Gazave E, Oliva M, Navarro A, Roberto R, Capozzi O, Archidiacono N, Della Valle G, Purgato S, Rocchi M, Konkel MK, Walker JA, Ullmer B, Batzer MA, Smit AF, Hubley R, Casola C, Schrider DR, Hahn MW, Quesada V, Puente XS, Ordoñez GR, López-Otín C, Vinar T, Brejova B, Ratan A, Harris RS, Miller W, Kosiol C, LawsonHA, TaliwalV, MartinsAL, Siepel A, Roychoudhury A, Ma X, Degenhardt J, Bustamante CD, Gutenkunst RN, Mailund T, Dutheil JY, Hobolth A, Schierup MH, Ryder OA, Yoshinaga Y, de Jong PJ, Weinstock GM, Rogers J, Mardis ER, GibbsRA, Wilson RK. 2011.Comparative and demographic analysis of orang-utan genomes. Nature 469:529-533.
40. López-Correa C, Brems H, Lázaro C, Marynen P, Legius E. 2000. Unequal meiotic crossover: a frequent cause of NF1 microdeletions. Am J Hum Genet 66:1969-1974.
41. López-CorreaC, Dorschner M, BremsH, LázaroC, ClementiM, Upadhyaya M, Dooijes D, Moog U, Kehrer-Sawatzki H, Rutkowski JL, Fryns JP, Marynen P, Stephens K, Legius E. 2001. Recombination hotspot in NF1 microdeletion patients. HumMol Genet 10:1387-1392.
42. McVean GA, Myers SR, Hunt S, Deloukas P, Bentley DR, Donnelly P. 2004. The finescale structure of recombination rate variation in the human genome. Science 304:581-584.
43. Mefford HC, Eichler EE. 2009. Duplication hotspots, rare genomic disorders, and common disease. Curr Opin Genet 19:196-204.
44. Messiaen L, Vogt J, Bengesser K, Fu C, Mikhail F, Serra E, Garcia-Linares C, Cooper DN, Lazaro C, Kehrer-Sawatzki H. 2011. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat 32:213-219.
45. Mills RE, Walter K, Stewart C, Handsaker RE, Chen K, Alkan C, Abyzov A, Yoon SC, Ye K, Cheetham RK, Chinwalla A, Conrad DF, Fu Y, Grubert F, Hajirasouliha I, Hormozdiari F, Iakoucheva LM, Iqbal Z, Kang S, Kidd JM, Konkel MK, Korn J, Khurana E, Kural D, Lam HY, Leng J, Li R, Li Y, Lin CY, Luo R, Mu XJ, Nemesh J, Peckham HE, Rausch T, Scally A, Shi X, Stromberg MP, Stütz AM, Urban AE, Walker JA, Wu J, Zhang Y, Zhang ZD, Batzer MA, Ding L, Marth GT, McVean G, Sebat J, Snyder M, Wang J, Ye K, Eichler EE, Gerstein MB, Hurles ME, Lee C, McCarroll SA, Korbel JO; 1000 Genomes Project. 2011. Mapping copy number variation by population-scale genome sequencing. Nature 470:59-65.
46. Myers S, Bottolo L, Freeman C, McVean G, Donnelly P. 2005. A fine-scale map of recombination rates and hotspots across the human genome. Science 310:321-324.
47. Myers S, Freeman C, Auton A, Donnelly P, McVeanG. 2008. A common sequencemotif associated with recombination hot spots and genome instability in humans. Nat Genet 40:1124-1129.
48. Neumann R, Lawson VE, Jeffreys AJ. 2010. Dynamics and processes of copy number instability in human gamma-globin genes. ProcNatlAcad SciUSA107:8304-8309.
49. Parvanov ED, Petkov PM, Paigen K. 2010. Prdm9 controls activation of mammalian recombination hotspots. Science 327:835.
50. Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Dollfus H, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dieux-Coeslier A, Bièche I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D; members of the NF France Network. 2010. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 31:E1506-E1518.
51. Pavlicek A, HouseR, Gentles AJ, Jurka J, MorrowBE. 2005.Traffic of genetic information between segmental duplications flanking the typical 22q11.2 deletion in velocardio-facial syndrome/DiGeorge syndrome. Genome Res 5:1487-1495.
52. Peters AD. 2008.Acombination of cis and trans control can solve the hotspot conversion paradox. Genetics 178:1579-1593.
53. Reiter LT, Hastings PJ, Nelis E, De Jonghe P, van Broeckhoven C, Lupski JR. 1998. Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am J Hum Genet 62:1023-1033.
54. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR. 1996. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 12:288-297.
55. Repping S, Skaletsky H, Lange J, Silber S, Van Der Veen F, Oates RD, Page DC, Rozen S. 2002. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 71:906-922.
56. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D; International SNPMapWorking Group. 2001. Amap of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933.
57. Shaw CJ, Withers MA, Lupski JR. 2004. Uncommon deletions of the Smith-Magenis syndrome region can be recurrent when alternate low-copy repeats act as homologous recombination substrates. Am J Hum Genet 75:75-81.
58. Stankiewicz P, Lupski JR. 2010. Structural variation in the human genome and its role in disease. Ann Rev Med 61:437-455.
59. Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J, Baker A, Jonasdottir A, Ingason A, Gudnadottir VG, Desnica N, Hicks A, Gylfason A, GudbjartssonDF, Jonsdottir GM, Sainz J, Agnarsson K, Birgisdottir B, Ghosh S, Olafsdottir A, Cazier JB, Kristjansson K, FriggeML, Thorgeirsson TE, Gulcher JR, Kong A, Stefansson K. 2005. A common inversion under selection in Europeans. Nat Genet 37:129-137.
60. Steinmann K, Cooper DN, Kluwe L, Chuzhanova NA, Senger C, Serra E, Lazaro C, Gilaberte M, Wimmer K, Mautner VF, Kehrer-Sawatzki H. 2007. Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. Am J Hum Genet 81:1201-1220.
61. Szostak JW, Orr-Weaver TL, Rothstein RJ, Stahl FW. 1983. The double-strand-break repair model for recombination. Cell 33:25-35.
62. Torres-Juan L, Rosell J, Sánchez-de-la-Torre M, Fibla J, Heine-Suñer D. 2007. Analysis of meiotic recombination in 22q11.2, a region that frequently undergoes deletions and duplications. BMC Med Genet 8:14.
63. Turner DJ, Miretti M, Rajan D, Fiegler H, Carter NP, Blayney ML, Beck S, Hurles ME. 2008. Germline rates of de novomeiotic deletions and duplications causing several genomic disorders. Nat Genet 40:90-95.
64. Ubeda F, Wilkins JF. 2011. The Red Queen theory of recombination hotspots. J Evol Biol 24:541-553.
65. Visser R, Shimokawa O, Harada N, Kinoshita A, Ohta T, Niikawa N, Matsumoto N. 2005. Identification of a 3.0-kb major recombination hotspot in patients with Sotos syndrome who carry a common 1.9-Mb microdeletion. Am J Hum Genet 76:52-67.
66. Webb AJ, Berg IL, Jeffreys A. 2008. Sperm cross-over activity in regions of the human genome showing extreme breakdown of marker association. Proc Natl Acad Sci USA 105:10471-10476.
67. Wells RD. 2007.Non-BDNA conformations, mutagenesis and disease. Trends Biochem Sci 32:271-278.
68. Zheng J, Khil PP, Camerini-Otero RD, Przytycka TM. 2010. Detecting sequence polymorphisms associated with meiotic recombination hotspots in the human genome. Genome Biol 11:R103.